Anti-TNF-Alpha Therapy
Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet’s disease in Taiwan
... of anti-TNF-alpha therapy was measured based on changes in Behçet ’ s Disease Current Activity Form (BDCAF) scores, prednisolone dosages and the immunosuppression load ...received ...
9
Paradoxical SAPHO syndrome observed during anti-TNF-α therapy for Crohn's disease
... an anti-TNF α inhibitor, we searched PubMed with Medical Subject Headings, with the terms “Crohn’s disease, anti-TNF- α , adalimumab, inflix- imab, etanercept, certolizumab, and golimumab ...
5
Inhibition of Th17 differentiation by anti TNF alpha therapy in uveitis patients with Behçet’s disease
... (PE)-labeled anti-human IL-17 monoclonal antibodies (R&D ...PE-labeled anti-human IL-17 antibodies and fluorescein isothiocyanate (FITC)-labeled anti-human CD4 ...PE-labeled anti-human ...
12
What Is the Personal Experience of IBD Patients about Their Anti TNF Alpha Therapy?
... biological therapy”; ” I prefer to take drug less often”; “I don’t like the idea of self-injecting”; “fewer side effects”; “medical supervision during ...both anti-TNF- α agents and chose IFX (and ...
12
TNF-α inhibitors: are they carcinogenic?
... Lymphoma has been reported after TNF- α receptor use. Braun et al reported 26 cases of lymphoma after treatment with etan- ercept (18 cases) and infliximab (8 cases) in patients being treated for RA and Crohn’s ...
7
Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies
... introduction of varying regimens based on administra- tion of anti-inflammatory drugs including methotrexate, glucocorticoid and anti-TNF-alpha monoclonal anti- bodies. Again, vast ...
8
A case of endobronchial tuberculosis developed under anti-TNF-alpha treatment
... cancer. Anti-TNF-alpha agents have been in- creasingly used in patients with rheumatoid arthritis ...under anti-TNF-alpha treatment was pre- sented in this ...under ...
5
Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis
... with anti-CTLA-4 antibody ...antibody therapy, however re-treatment with anti-CTLA-4 antibody following a total colectomy resulted in a rapid complete response accompanied by the development of a ...
5
Modulation of Anti-Tumor Necrosis Factor Alpha (TNF-α) Antibody Secretion in Mice Immunized with TNF-α Kinoid
... of TNF- ␣ -blocking agents have been developed so far: a soluble TNF-␣ receptor (etanercept) and TNF-binding monoclonal antibodies (MAbs) or MAb fragments, such as infliximab, adalimumab, golimumab, ...
5
Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries
... ARTiS, Anti-rheumatic Therapy in Sweden; ATTRA, Registry of patients treated with anti-tumor necrosis factor (TNF)-alpha drugs in the Czech Republic; BiOBADASeR, Spanish registry of ...
6
Golimumab: A novel human anti-TNF-α monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis
... novel anti-TNF- α monoclonal antibody that is in clinical development for the treatment of RA, psoriatic arthritis (PsA), and ankylosing spondylitis (AS), either as a first- line biologic therapy or ...
12
“Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti tumor necrosis factor alpha drugs: a nested case–control study”
... between anti- TNF drug treatment and an increase in all serious infec- tions in RA patients ...between anti-TNF therapy and increased risk of infection in RA patients ...receiving ...
7
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
... retrospectively from two cohorts that were treated either with rituximab or a second TNF α blocker. Treatments were not randomized and no information was available as to why patients were treated with either ...
9
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
... abatacept therapy in patients with rheumatoid ...al. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, ...
6
B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
... factors; RF) substantiate the conceivability for such a type of reaction. In fact, serum antibodies against the constant region of the heavy chain of IFX have been described [24, 25]. On the other hand, both epitopes IFX ...
10
Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
... used anti-TNF-α agents for treating 12 patients, the majority of whom were female (four males, eight ...topical therapy and second-line agents, being, in our case, corticosteroids and ...
8
Original Article The potential of TNF and TNFRSF1B gene polymorphism in predicting the clinical response of anti-TNF therapy in patients with juvenile idiopathic arthritis
... (rs1800629), TNF-238 (rs361525), TNFRSF1B (rs1061622), TRAF1/C5 (rs3761847), and PTP- N22 (rs2488457)) were selected for geno- typing in DNA according to previous studies, which have reported that these SNPs were ...
8
Clinical use of anti-TNF therapy and increased risk of infections
... Anti-TNF therapy should always be withheld until an active pneumococcal infection is treated. The choice of antibi- otic depends on the resistance and local epidemiological data. Empirical treatment ...
21
A national cohort study on pediatric Behçet’s disease: cross-sectional data from an Italian registry
... biologic therapy: 2 of them anti TNF-α (Infliximab) and 2 anti IL-1 (Anakinra), for severe ocular, neurological, GI and mucocutaneous ...used anti TNF-α ...of TNF-α ...
7
The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study
... started TNF-a blocking ...first TNF- a blocking agent. In these patients, TNF- a blocking therapy resulted in significantly increased bone-specific alkaline phosphatase, a marker of bone ...
10